Tafamidis

CAT: 0931-MF-0019035-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0931-MF-0019035-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
CAS Number
594839-88-0
Target
Others
Related Pathways
Others
Purity
0.9965
Bioactivity
Tafamidis (Fx-1006A) is a kinetic stabilizer of transthyretin (TTR) that prevents amyloidogenesis by wild-type and mutant TTRs. It binds to TTR with negative cooperativity (Kd1: 3 nM; Kd2: 278 nM) to stabilize the TTR dimer-dimer interface and inhibit tetrameric dissociation. Tafamidis stabilizes wild-type and clinically significant V30M and V122I mutant TTR amyloidogenic homotetramers (EC50s: 2.7-3.2 ?M) under fibril-promoting, denaturing, and physiological conditions in vitro. It stabilizes TTR heterotetramers containing wild-type and mutant subunits ex vivo in human plasma derived from patients carrying V30M or V1221 mutations when used at a concentration of 7.2 ?M. Formulations containing tafamidis have been used for the treatment of familial amyloid polyneuropathy.
Smiles
ClC=1C=C(C=2OC=3C(N2)=CC=C(C(O)=O)C3)C=C(Cl)C1
Molecular Formula
C14H7Cl2NO3
Molecular Weight
308.12
Shipping Conditions
Cool pack
Storage Temperature
-20°C

Alternative Products

CatalogName
M18866-01Tafamidis
MBS3842643-01Tafamidis meglumine
HY-14852S-01Tafamidis-d3
MBS384733-01Tafamidis (Fx1006A)

Popular Products